Renal failure following gentamicin in combination with clindamycin

Area of Science:

• Pharmacology
• Nephrology
• Clinical Medicine

Background:

• Gentamicin is an aminoglycoside antibiotic known for potential nephrotoxicity.
• Clindamycin is a lincosamide antibiotic with a generally favorable renal safety profile.
• The combined nephrotoxic potential of gentamicin and clindamycin has not been extensively studied.

Observation:

• Three patients developed acute renal failure (ARF) during treatment with a combination of gentamicin and clindamycin.
• No other predisposing factors for ARF were identified in these patients.
• Renal function significantly improved in all patients after the cessation of antibiotic therapy.

Findings:

• The temporal association between the administration of gentamicin and clindamycin and the onset of ARF suggests a causal link.
• The observed improvement in renal function upon drug withdrawal supports the hypothesis of antibiotic-induced nephrotoxicity.
• Complete or partial recovery of renal function occurred in all affected patients.

Implications:

• Clinicians should be aware of the potential for combined nephrotoxicity when prescribing gentamicin and clindamycin.
• Close monitoring of renal function is crucial for patients receiving this antibiotic combination.
• Further research may be warranted to elucidate the mechanisms of this combined nephrotoxicity and to establish safer prescribing guidelines.